University of Cambridge > Talks.cam > Science@Darwin > Structure Based Drug Design

  Browse A-Z

Log in

University Account External (via Google)

🔐 Log In

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

ℹ️ Information

Structure Based Drug Design

Download to your calendar using vCal

If you have a question about this talk, please contact Claus Bendtsen .

The first AstraZeneca hosted seminar at our Darwin building on the Cambridge Science Park. The seminar will consist of three presentations:

1) A dual fragment/biochemical screening approach to targeting InhA, a Tuberculosis target by Jon Read from AstraZeneca

2) Structure-based design of potent and selective inhibitors of the metabolic kinase PFKFB3 by Judit Debreczeni from AstraZeneca

3) Crystal Structure of a Class C GPCR – metabotropic glutamate receptor 5 (mGluR5) by Andrew Doré from Heptares

Abstracts & registration @ https://eventbrite.co.uk/event/14503848401

This talk is part of the Science@Darwin series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

The Tower Room, Selwyn College, Grange Road, Cambridge CB3 9DQ FW11, William Gates Building. Zoom link: https://cl-cam-ac-uk.zoom.us/j/4361570789?pwd=Nkl2T3ZLaTZwRm05bzRTOUUxY3Q4QT09&from=addon Average on weekdays: 8804.80612245 kWh

Other talks

Proteomics: Expression Analysis and Subcellular Localisation Title to be confirmed Feedback and the circumgalactic medium Title TBC Why people with schizophrenia die earlier? Mortality and accelerated ageing John Kendrew Lecture - Title TBC
 

© 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity